Attractive Stocks Alert: MannKind (NASDAQ: MNKD), Gilead Sciences, Inc ... iStreetWire Elotuzumab, for instance, is associated with Bristol-Myers Squibb (BMY), while Daclizumab is being developed with Biogen Idec. AbbVie Inc (NYSE:ABBV) ranged in price between $52.02 -$53.21 and dropped -3.11% to close at $52.63. The stock moved up ... |
